SQOR and ischemia: In conditions with low H2S signaling (such as heart failure with reduced ejection fraction), SQOR inhibition may be beneficial to restore H2S levels, whereas in conditions primarily involving mitochondrial dysfunction (such as ischemia–reperfusion injury), SQOR activation may be advantageous to support mitochondrial function.